Cerecor Announces $43 Million Deal with AYTU BioScience to Sell Pediatric Portfolio and Advance Towards NDA
It was announced today that Rockville, Maryland-based Cerecor Inc. (NASDAQ: CERC) has entered into an asset purchase agreement with AYTU BioScience, Inc. (“AYTU”) to sell Cerecor’s Pediatric Portfolio in a deal valued in excess of $32 million.
Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for pediatric rare diseases. Earlier this year the company received Fast Track Designation for its lead product candidate, CERC-801 and expects to receive its first FDA approval within the next 18 months.
Visit https://lnkd.in/e8zm7df to read more.
{iframe}https://www.linkedin.com/posts/biobuzz_cerecor-announces-43-million-deal-with-aytu-activity-6589557870222721024-O5Oj/{/iframe}